US Patent Issued to Antecip Bioventures II on Nov. 18 for "Compounds and combinations thereof for treating neurological and psychiatric conditions" (New York Inventor)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,155, issued on Nov. 18, was assigned to Antecip Bioventures II LLC (New York).

"Compounds and combinations thereof for treating neurological and psychiatric conditions" was invented by Herriot Tabuteau (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to administration of a combination of: 1) about 100-110 mg, about 104-106 mg, or about 105 mg of bupropion hydrochloride, or a molar equivalent amount of a free base form or another salt form of bupropion; and 2) about 40-50 mg, about 44-46 mg, or about 45 mg of dextromethorphan hydrobromide, or a molar equivalent amount of a free base form or another salt form of dextrom...